Thomas Pagliardini
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Journal: Bone marrow transplantation
Published: December 06, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Journal: Bone marrow transplantation
Published: June 01, 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: September 02, 2022
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 29, 2021
Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic.
Journal: Bone marrow transplantation
Published: November 30, 2020
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing.
Journal: Nature communications
Published: November 30, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
Journal: Bone marrow transplantation
Published: June 15, 2020
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: May 28, 2020
Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 07, 2020
Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy.
Journal: Journal of leukocyte biology
Published: February 18, 2020
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: May 06, 2019
Last Updated: 09/26/2026